37 related articles for article (PubMed ID: 17160935)
21. [Application of myc family genes to therapy of malignant brain tumors].
Kuchino Y; Kitanaka C; Asai A
Tanpakushitsu Kakusan Koso; 1995 Dec; 40(17):2713-9. PubMed ID: 8584726
[No Abstract] [Full Text] [Related]
22. A genetically defined normal human somatic cell system to study ras oncogenesis in vivo and in vitro.
O'Hayer KM; Counter CM
Methods Enzymol; 2006; 407():637-47. PubMed ID: 16757358
[TBL] [Abstract][Full Text] [Related]
23. [Approach to human glioma cells using antisense molecules].
Yoshida S; Tanaka R
No To Shinkei; 1995 Sep; 47(9):823-8. PubMed ID: 7546930
[No Abstract] [Full Text] [Related]
24. [Gene therapy for brain tumors: cytokine gene therapy using DNA/liposome (series 3)].
Okada H; Okamoto S; Yoshida J
No Shinkei Geka; 1994 Nov; 22(11):999-1004. PubMed ID: 7816184
[No Abstract] [Full Text] [Related]
25. Molecular targeting for malignant gliomas (Review).
Kondo Y; Hollingsworth EF; Kondo S
Int J Oncol; 2004 May; 24(5):1101-9. PubMed ID: 15067331
[TBL] [Abstract][Full Text] [Related]
26. Telomerase inhibition in malignant gliomas: a systematic review.
D'Alessandris QG; Battistelli M; Pennisi G; Offi M; Martini M; Cenci T; Falchetti ML; Lauretti L; Olivi A; Pallini R; Montano N
Expert Rev Mol Med; 2023 Mar; 25():e10. PubMed ID: 36919343
[TBL] [Abstract][Full Text] [Related]
27. [Progress in the local treatment of malignant brain glioma].
Sun JJ; Wang ZY
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(20):1438-9. PubMed ID: 16029662
[No Abstract] [Full Text] [Related]
28. Immunological considerations of modern animal models of malignant primary brain tumors.
Sughrue ME; Yang I; Kane AJ; Rutkowski MJ; Fang S; James CD; Parsa AT
J Transl Med; 2009 Oct; 7():84. PubMed ID: 19814820
[TBL] [Abstract][Full Text] [Related]
29. [Primary malignant brain tumors].
Genot JY
Bull Cancer; 1994; 81 Suppl 1():15s-19s. PubMed ID: 7727850
[No Abstract] [Full Text] [Related]
30. [Antisense DNA].
Shoji Y; Shimada J; Mizushima Y
Gan To Kagaku Ryoho; 1993 Oct; 20(13):1899-907. PubMed ID: 8215461
[TBL] [Abstract][Full Text] [Related]
31. [Study on combined gene therapy for malignant gliomas transfected with antisense hTERT/PTEN in vitro and in vivo].
You YP; Fu Z; Zhao P; Wang CZ; Liu N; Lu AL
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Dec; 23(6):605-9. PubMed ID: 17160935
[TBL] [Abstract][Full Text] [Related]
32. Telomerase as a therapeutic target for malignant gliomas.
Komata T; Kanzawa T; Kondo Y; Kondo S
Oncogene; 2002 Jan; 21(4):656-63. PubMed ID: 11850793
[TBL] [Abstract][Full Text] [Related]
33. [Gene therapy for brain tumors--present conditions and prospects].
Nakahara N; Yoshida J
Gan To Kagaku Ryoho; 2005 Apr; 32(4):458-62. PubMed ID: 15853210
[TBL] [Abstract][Full Text] [Related]
34. [Application of antisense human telomerase RNA toward cancer therapy].
Naka K; Yokozaki H; Tahara H; Tahara E
Nihon Rinsho; 1998 May; 56(5):1131-5. PubMed ID: 9613109
[TBL] [Abstract][Full Text] [Related]
35. Telomerase therapeutics: telomeres recognized as a DNA damage signal: commentary re: K. Kraemer et al., antisense-mediated hTERT inhibition specifically reduces the growth of human bladder cancer cells. Clin. Cancer Res., 9: 3794-3800, 2003.
Shay JW
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3521-5. PubMed ID: 14506137
[No Abstract] [Full Text] [Related]
36. [Gene therapy for brain tumors: antitumor effects of introduction of antisense and tumor suppressor gene (series 2)].
Nitta T
No Shinkei Geka; 1994 Oct; 22(10):903-9. PubMed ID: 7969756
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
